中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Menu
Issue 12
Dec.  2016
Turn off MathJax
Article Contents
Abstract
References
Article Navigation >  Journal of Clinical Hepatology  > 2016  >  32(12): 2379-2382

Ultrasound elastography for evaluation of classification of liver fibrosis

DOI: 10.3969/j.issn.1001-5256.2016.12.032
  • Published Date: 2016-12-20
    Abstract
  • Liver fibrosis is the important stage of most liver diseases,and early and accurate diagnosis of classification of liver fibrosis plays an important role in developing individualized treatment regimens and reducing mortality rates. Ultrasound elastography has become popular in clinical physicians due to its unique advantages. This article compares the accuracy,sensitivity,and specificity of transient elastography,acoustic radiation force impulse elastography,real- time shear wave elastography,and real- time tissue elastography in the diagnosis of classification of liver fibrosis and helps to enhance clinical physicians' knowledge of advantages and shortcomings of various ultrasound elastography methods in the diagnosis of classification of liver fibrosis.

     

    • FullText(HTML)
    • References(37)
  • [1]TSOCHATZIS EA,BOSCH J,BURROUGHS AK,et al.Liver cirrhosis[J].Lancet,2014,383(9930):1749-1761.
    [2]MARCELLIN P,GANE E,BUTI M,et al.Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B:a 5-year open-label follow-up study[J].Lancet,2013,381(9865):468-475.
    [3]FU LZ,ZHENG T,ZHANG YS.Advances in understanding the role of TGF-β/Smad signalling pathways in the pathogenesis of liver fibrosis[J].Chin J Clin Pharmacol Ther,2014,19(10):1189-1195.(in Chinese)付玲珠,郑婷,张永生.TGF-β/Smad信号转导通路与肝纤维化研究进展[J].中国临床药理学与治疗学,2014,19(10):1189-1195.
    [4]COLLOREDO G,GUIDO M,SONZOGNI A,et al.Impact of liver biopsy size on histological evaluation of chronic viral hepatitis:the smaller the sample,the milder the disease[J].J Hepatol,2003,39(39):239-244.
    [5]CASTERA L,WINNNOCK M,PAMBRUN E,et al.Comparison of transient elastography(Fibro Scan),Fibro Test,APRI and two algorithms combining these non-invasive tests for liver fibrosis staging in HIV/HCV coinfected patients:ANRS CO13 HEPAVIH and FIBROSTIC collaboration[J].HIV Med,2013,15(1):30-39.
    [6]LI SM,LI GX,FU DM,et al.Liver fibrosis evaluation by ARFI and APRI in chronic hepatitis C[J].World J Gastroenterol,2014,20(28):9528-9533.
    [7]TADA T,KUMADA T,TOYODA H,et al.Utility of real-time shear wave elastography for assessing liver fibrosis in patients with chronic hepatitis C infection without cirrhosis:comparison of liver fibrosis indices[J].Hepatol Res,2015,45(10):440-447.
    [8]TAMAKI N,KUROSAKI M,MATSUDA S,et al.Prospective comparison of real-time tissue elastography and serum fibrosis markers for the estimation of liver fibrosis in chronic hepatitis C patients[J].Hepatol Res,2014,44(7):105-114.
    [9]PERAZZO H,VELOSE V G,GRINSZTEJN B,et al.Factors that could impact on liver fibrosis staging by transient elastography[J].Int J Hepatol,2015,2015(2):1-5.
    [10]WANG H,JIA JD.Strategies for hepatitis C by the American Associan for Study of Liver Diseases(AASLD)in 2009[J].Chin Hepatol,2009,14(3):231-233.(in Chinese)王慧,贾继东.美国肝病学会2009年版丙型肝炎指南要点介绍[J].肝脏,2009,14(3):231-233.
    [11]ZHANG D,CHEN M,WANG R,et al.Comparison of acoustic radiation force impulse imaging and transient elastography for noninvasive assessment of liver fibrosis in patients with chronic hepatitis B[J].Ultrasound Med Biol,2014,41(1):7-14.
    [12]DEFFIEUX T,GENNISSON JL,BOUSQUET L,et al.Investigating liver stiffness and viscosity for fibrosis,steatosis and activity staging using shear wave elastography[J].J Hepatol,2015,62(2):317-324.
    [13]MENG F,ZHENG Y,ZHANG Q,et al.Noninvasive evaluation of liver fibrosis using real-time tissue elastography and transient elastography(Fibro Scan)[J].J Ultrasound Med,2015,34(3):403-410.
    [14]BOTA S,HERKNER H,SPOREA I,et al.Meta-analysis:ARFI elastography versus transient elastography for the evaluation of liver fibrosis[J].Liver Int,2013,33(8):1138-1147.
    [15]LIU H,FU J,HONG R,et al.Acoustic radiation force impulse elastography for the non-invasive evaluation of hepatic fibrosis in non-alcoholic fatty liver disease patients:a systematic review&meta-analysis[J].PLo S One,2015,10(7):e0127782.
    [16]KARLAS T,DIETRICH A,PETER V,et al.Evaluation of transient elastography,acoustic radiation force impulse imaging(ARFI),and enhanced liver function(ELF)score for detection of fibrosis in morbidly obese patients[J].PLo S One,2015,10(11):e0141649.
    [17]COLOMBO S,BUONOCORE M,POGGIO AD,et al.Head-to-head comparison of transient elastography(TE),real-time tissue elastography(RTE),and acoustic radiation force impulse(ARFI)imaging in the diagnosis of liver fibrosis[J].J Gastroenterol,2012,47(4):461-469.
    [18]GERBER L,KASPER D,FITTING D,et al.Assessment of liver fibrosis with 2-D shear wave elastography in comparison to transient elastography and acoustic radiation force impulse imaging in patients with chronic liver disease[J].Ultrasound Med Biol,2015,41(9):2350-2359.
    [19]THIELE M,DETLEFSEN S,SEVELSTED ML,et al.Transient and 2-Dimensional shear-wave elastography provide comparable assessment of alcoholic liver fibrosis and cirrhosis[J].Gastroenterology,2015,150(1):123-133.
    [20]FERRAIOLI G,PAREKH P,LEVITOV AB,et al.Shear wave elastography for evaluation of liver fibrosis[J].Eur J Gastroenterol Hepatol,2014,33(33):197-203.
    [21]SHAN QY,LIU BX,TIAN WS,et al.Elastography of shear wave speed imaging for the evaluation of liver fibrosis:a meta-analysis[J].Hepatol Res,2016.[Epub ahead of print]
    [22]LI C,ZHANG C,LI J,et al.Diagnostic accuracy of real-time shear wave elastography for staging of liver fibrosis:a meta-analysis[J].Med Sci Monit,2016,22:1349-1359.
    [23]HU Q,ZHU S Y,KANG L K,et al.Non-invasive assessment of liver fibrosis using real-time tissue elastography in patients with chronic hepatitis B[J].Clin Radiol,2013,69(2):194-199.
    [24]KOIZUMI Y,HIROOKA M,KISAKA Y,et al.Liver fibrosis in patients with chronic hepatitis C:noninvasive diagnosis by means of real-time tissue elastography—establishment of the method for measurement[J].Radiology,2011,258(2):610-617.
    [25]WU T,REN J,CONG SZ,et al.Accuracy of real-time tissue elastography for the evaluation of hepatic fibrosis in patients with chronic hepatitis B:a prospective multicenter study[J].Dig Dis,2014,32(6):791-799.
    [26]KOBAYASHI K,NAKAO H,NISHIYAMA T,et al.Diagnostic accuracy of real-time tissue elastography for the staging of liver fibrosis:a meta-analysis[J].Eur Radiol,2015,25(1):230-238.
    [27]ZHENG YP,MAK TM,HUANG ZM,et al.Liver fibrosis assessment using transient elastography guided with real-time b-mode ultrasound imaging[J].Ultrasound Med Biol,2013,39(6):956-966.
    [28]ZHANG GS,WANG TY,XU YQ,et al.Diagnostic value of realtime tissue elastography for liver fibrosis in patients with chronic hepatitis B[J].J Clin Hepatol,2014,30(7):616-619.(in Chinese)张国盛,王天懿,徐有青,等.实时组织弹性成像技术对慢性乙型肝炎肝纤维化的诊断价值[J].临床肝胆病杂志,2014,30(7):616-619.
    [29]CHENG JY,MA H.Research progress in noninvasive diagnosis of liver fibrosis in patients with chronic liver diseases[J].J Clin Hepatol,2014,30(2):178-181.(in Chinese)程捷瑶,马红.慢性肝病肝纤维化无创诊断的研究进展[J].临床肝胆病杂志,2014,30(2):178-181.
    [30]ROBERT P,MYERS,POMIER-LAYRARGUE G,et al.Feasibility and diagnostic performance of the Fibro Scan XL probe for liver stiffness measurement in overweight and obese patients[J].Hepatology,2012,55(1):199-208.
    [31]ZHOU JL,WEI W,YOU H.Progress in clinical studies of nonivasive early diagnosis of liver fibrosis and cirrhosis[J].J Clin Hepatol,2014,30(7):604-607.(in Chinese)周家玲,魏巍,尤红.肝纤维化无创诊断技术的临床研究及进展[J].临床肝胆病杂志,2014,30(7):604-607.
    [32]BOHTE AE,NIET AD,JANSEN L,et al.Non-invasive evaluation of liver fibrosis:a comparison of ultrasound-based transient elastography and MR elastography in patients with viral hepatitis B and C[J].Eur Radiol,2014,24(3):638-648.
    [33]FRANCHIABELLA S,ELIE C,CORREAS JM,et al.Ultrasound elastography:advantages,limitations and artefacts of the different techniques from a study on a phantom[J].Diagn Interv Imaging,2013,94(5):497-501.
    [34]WU Q,XU GH.Recent research findings on non-invasive diagnosis of liver fibrosis[J].J Clin Hepatol,2015,31(2):295-299.(in Chinese)武琼,徐光华.肝纤维化非创伤性诊断的新近认识[J].临床肝胆病杂志,2015,31(2):295-299.
    [35]GOERTZ RS,STURM J,PFEIFER L,et al.ARFI cut-off values and significance of standard deviation for liver fibrosis staging in patients with chronic liver disease[J].Ann Hepatol,2013,12(6):935-941.
    [36]FRULIO N,TRILLAUD H.Ultrasound elastography in liver[J].Ultrasound Med Biol,2013,94(5):515-534.
    [37]TOMENO W,YONEDA M,IMAJO K,et al.Evaluation of the liver fibrosis index calculated by using real-time tissue elastography for the non-invasive assessment of liver fibrosis in chronic liver diseases[J].Hepatol Res,2013,43(7):735-742.
    • Relative Articles

  • Relative Articles

    [1]Jinqiu YANG, Wenxia ZHAO, Cheng ZHOU, Tong LIU. Risk factors for the development of advanced liver fibrosis in nonalcoholic fatty liver disease and establishment of a nomogram model[J]. Journal of Clinical Hepatology, 2024, 40(8): 1579-1584. doi: 10.12449/JCH240812
    [2]Jing KUANG, Shuangqin TENG, Tongtong SHEN, Yiran YAN, Wei WANG, Chuan SHEN, Caiyan ZHAO. Risk factors for portopulmonary hypertension in liver cirrhosis and construction of a predictive model[J]. Journal of Clinical Hepatology, 2024, 40(9): 1802-1806. doi: 10.12449/JCH240914
    [3]Decai KONG, Xiaojing ZHANG, Yangguang YUN, Haoyu DUAN, Junfeng YE. Risk factors for biliary stricture and prognosis after orthotopic liver transplantation[J]. Journal of Clinical Hepatology, 2024, 40(11): 2253-2259. doi: 10.12449/JCH241119
    [4]Mingqiang ZHU, Dashuai YANG, Junpeng PEI, Xiangyun XIONG, Yang SU, Youming DING. Analysis of influencing factors on biliary complications after orthotopic liver transplantation[J]. Journal of Clinical Hepatology, 2023, 39(7): 1627-1632. doi: 10.3969/j.issn.1001-5256.2023.07.017
    [5]Sufang LU, Rui HUANG, Hongli ZHAO, Dandan WANG, Yuzhen DING, Hong ZHOU. Value of a risk assessment model in predicting venous thromboembolism in patients with liver failure after artificial liver support therapy[J]. Journal of Clinical Hepatology, 2023, 39(3): 613-619. doi: 10.3969/j.issn.1001-5256.2023.03.019
    [6]Bingbing ZHU, Jinxiang YANG, Qun ZHANG, Fangyuan GAO, Xianbo WANG. Risk factors for the 90-day prognosis of patients with type I hepatorenal syndrome and establishment of a predictive model[J]. Journal of Clinical Hepatology, 2022, 38(7): 1561-1565. doi: 10.3969/j.issn.1001-5256.2022.07.019
    [7]Perioperative Management Group, Chinese Society of Organ Transplantation, Chinese Medical Association. Expert consensus on perioperative vascular complications for liver transplantation(2021)[J]. Journal of Clinical Hepatology, 2021, 37(9): 2054-2057. doi: 10.3969/j.issn.1001-5256.2021.09.010
    [8]Bing GUO, Mingquan PANG, Xiaolei XU, Junwei HAN, Haijiu WANG. Establishment and evaluation of a nomogram for predicting post-hepatectomy complications in two types of hepatic echinococcosis[J]. Journal of Clinical Hepatology, 2021, 37(11): 2626-2631. doi: 10.3969/j.issn.1001-5256.2021.11.027
    [9]Yun ZHAO, Lijin ZHAO. Research advances in the risk factors for infection after liver transplantation[J]. Journal of Clinical Hepatology, 2021, 37(8): 1957-1962. doi: 10.3969/j.issn.1001-5256.2021.08.046
    [10]Mingwei LI, Jian GAO, Xiangwei ZHAI, Xiangjun QIAN, Xiajie WEN, Mingjie YAO, Zhaojun DUAN, Erjiang ZHAO, Ling ZHANG, Fengmin LU. Construction and analysis of a predictive model for posthepatectomy recurrence in patients with hepatocellular carcinoma based on preoperative CXCL13 measurement[J]. Journal of Clinical Hepatology, 2021, 37(4): 823-828. doi: 10.3969/j.issn.1001-5256.2021.04.020
    [11]Wang Han, Zuo XiangRong, Cao Quan. Predictive factors and interventions for prolonged mechanical ventilation after liver transplantation[J]. Journal of Clinical Hepatology, 2020, 36(7): 1658-1662. doi: 10.3969/j.issn.1001-5256.2020.07.047
    [12]Zhang DaLi, Feng DanNi, Zhang LiJuan, Tang RuJia, He Xi, Zhou Xia, Gao YinJie, Liu ZhenWen, Liu HongLing. Risk factors for recurrence after liver transplantation in patients with hepatocellular carcinoma and their prognosis[J]. Journal of Clinical Hepatology, 2020, 36(9): 1985-1989. doi: 10.3969/j.issn.1001-5256.2020.09.015
    [13]Zheng WeiPing, Shen ZhongYang. Risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma and related control strategies[J]. Journal of Clinical Hepatology, 2019, 35(11): 2391-2395. doi: 10.3969/j.issn.1001-5256.2019.11.003
    [14]Chen Long, Li Yue. The risk factors and prediction systems for posthepatectomy complications[J]. Journal of Clinical Hepatology, 2019, 35(1): 217-221. doi: 10.3969/j.issn.1001-5256.2019.01.048
    [15]Jie EnBo, Xuan FengHui, Sun XiaoDong, Sun DaWei, Lu: GuoYue. An analysis of risk factors for early complications after liver transplantation[J]. Journal of Clinical Hepatology, 2018, 34(6): 1282-1288. doi: 10.3969/j.issn.1001-5256.2018.06.030
    [16]Zhang YinTao, Meng JinYing, Guo ChunGuang, Wang Hua. Risk factors for biliary complications after common bile duct exploration combined with primary suture[J]. Journal of Clinical Hepatology, 2017, 33(2): 304-307. doi: 10.3969/j.issn.1001-5256.2017.02.021
    [17]Wang XinWei, Zhao ZongGang. Risk factors for infectious complications after hepatectomy in patients with intrahepatic bile duct stones[J]. Journal of Clinical Hepatology, 2017, 33(9): 1754-1757. doi: 10.3969/j.issn.1001-5256.2017.09.025
    [18]Wang MingYue, Lu ZhiYan. Imaging evaluation of complications after liver transplantation[J]. Journal of Clinical Hepatology, 2016, 32(12): 2295-2299. doi: 10.3969/j.issn.1001-5256.2016.12.013
    [19]Lu: GuoYue. Risk factors for biliary complications after liver transplantation from donation after cardiac death[J]. Journal of Clinical Hepatology, 2015, 31(12): 2027-2030. doi: 10.3969/j.issn.1001-5256.2015.12.009
    [20]Chen Man, Zhang Xia. Research advances in molecular prediction of recurrence and metastasis of primary liver cancer after liver transplantation[J]. Journal of Clinical Hepatology, 2014, 30(12): 1361-1365. doi: 10.3969/j.issn.1001-5256.2014.12.032
    • Supplements(0)
    • Cited By

  • Cited by

    Periodical cited type(4)

    1. 李正优，李荷，周俊. 预见性护理结合舒适护理干预在肝移植术后患者中的应用. 西藏医药. 2024(06): 123-125 .
    2. 李珊珊，王媛，高春辉. 早期下床活动对肝移植术后患者胃肠功能及下肢血流的影响. 国际移植与血液净化杂志. 2023(01): 41-44 .
    3. 张欣悦，王海刚，王昊，杨传伟. 他克莫司治疗1例肝移植术后患者的药学监护. 中国医药导报. 2023(14): 183-187 .
    4. 种庚，彭晓春，吴若林，赵红川，邵敏. 成人肝移植术后早期严重并发症相关危险因素分析. 肝胆外科杂志. 2022(06): 454-459 .

    Other cited types(0)

  • Created with Highcharts 5.0.7Amount of accessChart context menuAbstract Views, HTML Views, PDF Downloads StatisticsAbstract ViewsHTML ViewsPDF Downloads2024-052024-062024-072024-082024-092024-102024-112024-122025-012025-022025-032025-0402.557.51012.515
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 29.9 %FULLTEXT: 29.9 %META: 63.7 %META: 63.7 %PDF: 6.4 %PDF: 6.4 %FULLTEXTMETAPDF
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 5.8 %其他: 5.8 %其他: 1.5 %其他: 1.5 %Greece: 0.4 %Greece: 0.4 %India: 0.3 %India: 0.3 %Russian Federation: 0.1 %Russian Federation: 0.1 %United States: 0.4 %United States: 0.4 %[]: 0.5 %[]: 0.5 %上海: 3.3 %上海: 3.3 %东莞: 0.2 %东莞: 0.2 %中山: 0.1 %中山: 0.1 %乌鲁木齐: 0.4 %乌鲁木齐: 0.4 %保定: 0.2 %保定: 0.2 %包头: 0.1 %包头: 0.1 %北京: 4.3 %北京: 4.3 %十堰: 0.1 %十堰: 0.1 %南京: 0.6 %南京: 0.6 %南充: 0.4 %南充: 0.4 %南宁: 0.3 %南宁: 0.3 %南阳: 0.1 %南阳: 0.1 %卡纳塔克: 0.5 %卡纳塔克: 0.5 %印度中央邦: 0.3 %印度中央邦: 0.3 %厦门: 0.2 %厦门: 0.2 %台州: 0.4 %台州: 0.4 %合肥: 0.1 %合肥: 0.1 %吉林: 0.4 %吉林: 0.4 %哈密: 0.1 %哈密: 0.1 %哥伦布: 0.1 %哥伦布: 0.1 %大连: 1.4 %大连: 1.4 %天津: 1.7 %天津: 1.7 %宁波: 0.6 %宁波: 0.6 %安康: 0.4 %安康: 0.4 %宜昌: 0.1 %宜昌: 0.1 %密蘇里城: 0.2 %密蘇里城: 0.2 %常德: 0.1 %常德: 0.1 %广州: 2.6 %广州: 2.6 %弗吉尼亚州: 0.1 %弗吉尼亚州: 0.1 %张家口: 2.2 %张家口: 2.2 %意法半: 0.1 %意法半: 0.1 %成都: 0.8 %成都: 0.8 %新乡: 0.2 %新乡: 0.2 %新加坡: 0.1 %新加坡: 0.1 %昆明: 1.1 %昆明: 1.1 %晋城: 0.2 %晋城: 0.2 %杭州: 2.0 %杭州: 2.0 %桂林: 0.3 %桂林: 0.3 %武汉: 0.7 %武汉: 0.7 %江门: 0.1 %江门: 0.1 %济南: 0.4 %济南: 0.4 %海得拉巴: 0.2 %海得拉巴: 0.2 %深圳: 0.2 %深圳: 0.2 %温州: 0.2 %温州: 0.2 %湖州: 0.5 %湖州: 0.5 %湘潭: 0.1 %湘潭: 0.1 %漯河: 0.2 %漯河: 0.2 %濮阳: 0.1 %濮阳: 0.1 %烟台: 0.1 %烟台: 0.1 %眉山: 0.1 %眉山: 0.1 %石家庄: 0.3 %石家庄: 0.3 %福州: 0.2 %福州: 0.2 %绍兴: 0.1 %绍兴: 0.1 %耶拿: 0.2 %耶拿: 0.2 %芒廷维尤: 38.8 %芒廷维尤: 38.8 %芝加哥: 0.2 %芝加哥: 0.2 %莫斯科: 1.5 %莫斯科: 1.5 %衡水: 0.3 %衡水: 0.3 %衢州: 0.2 %衢州: 0.2 %西宁: 14.4 %西宁: 14.4 %西安: 0.3 %西安: 0.3 %贵阳: 0.1 %贵阳: 0.1 %赣州: 0.4 %赣州: 0.4 %赤峰: 0.1 %赤峰: 0.1 %运城: 1.5 %运城: 1.5 %邯郸: 0.1 %邯郸: 0.1 %重庆: 0.4 %重庆: 0.4 %长春: 0.9 %长春: 0.9 %长沙: 0.9 %长沙: 0.9 %香港: 0.2 %香港: 0.2 %其他其他GreeceIndiaRussian FederationUnited States[]上海东莞中山乌鲁木齐保定包头北京十堰南京南充南宁南阳卡纳塔克印度中央邦厦门台州合肥吉林哈密哥伦布大连天津宁波安康宜昌密蘇里城常德广州弗吉尼亚州张家口意法半成都新乡新加坡昆明晋城杭州桂林武汉江门济南海得拉巴深圳温州湖州湘潭漯河濮阳烟台眉山石家庄福州绍兴耶拿芒廷维尤芝加哥莫斯科衡水衢州西宁西安贵阳赣州赤峰运城邯郸重庆长春长沙香港

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (1818) PDF downloads(474) Cited by(4)
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[2389]YesterdayPV[5285]TodayIP[1972]TodayPV[4352]Online[53]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return